Acarix USA, Inc.
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD).
The CE-approved and FDA DeNovo-cleared CADScor®System is intended for patients experiencing chest pain with suspected CAD and is designed to help reduce millions of unnecessary, invasive, costly diagnostic procedures.
The CADScor®System uses advanced acoustics and AI technology to rule out CAD non-invasively in less than 10 minutes, with at least 96.2% certainty.
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth! Yes
First time Exhibitor? Yes